CTN :40508744
18 Jun, 2025
NA
Tender For supply of t.e.no. gmscl/d-754/rc/2025-26 (tablet & capsule, injection, miscellaneous items (100 items)) - tablet chlorine 0.5 gm with isi mark, 522000, each prolonged release tablet contains: etophylline 77 mg and theophylline ip 23 mg, tablets glibenclamide 5mg, 27000, each coated tablet contain imipramine hydrochloride ip 25mg, tablet mefloquine 250 mg, 17000, each tablet contains: methotrexate ip 2.5 mg, capsules rifampicin 150 mg, 6000, each coated tablet contains : verapamil hcl ip 40 mg., tablet warfarin sodium 5 mg, 14000, each enteric coated tablet contains:acetyl salicylic acid ip 150 mg, tablet glyceryl trinitrate (sublingual) 0.5 mg, 11000, each coated sustained/modified release tablets contains:metformin hydrochloride ip1000 mg, kit 2/ green colour secnidazole tablet & fluconazole tablet, 103000, each tablet contains:-zidovudine 300 mg plus lamivudine 150 mg plus navirapine 200 mg, tablet efavirenz 600 mg, 2000, each tablet contains-:stavudin ip 30mg &lamivudine ip 150mg, capsule atazanavir 300 mg, 8000, each tablet contains:-lopinavir ip 200mg &ritonavir ip 50mg., tablet efavirenz 200 mg, 1000, each tablet contains:nevirapine ip 50mg., tablet lopinavir 100 mg plus ritonavir 25 mg, 3000, each tablet contains:- nevirapine 200 mg, tablet tenofovir 300 mg plus lamivudine 300 mg plus efavirenz 600 mg, 12000, each tablet contains :-zidovudine ip 300 mg, tablet lamivudine 150 mg, 17000, each film coated tablet contains:levetiracetam 500 mg, tablet methotrexate 5 mg, 26000, each uncoated tablet contains:lactic acid bacillius not less120 million spores, tablet propylthiouracil 50 mg, 12000, each controlled release 1000 mg tablet contains sodium valproate 666 mg ip plus valproic acid 290 mg ip, tablet warfarin sodium 2 mg, 7000, each coated tablet contains: quinine sulphate ip 600 mg, tablet artesunate, pyrimethamine & sulphadoxine {150 mg plus (25 mgplus 500 mg)} (9-14 years), 8000, each tablet contains: sofosbuvir 400 mg and velapatasvir 100 mg, calcium gluconate injection (for im/slow iv use), 141500, each vial contains:ceftazidime (pentahydrate) ip eq.to 250 mg of ceftazidime sodium, carbonate or argenine q.s., injection pheniramine maleate 22.75 mg/ml, 187100, each ml contains:(i) sodium diatrizoate 80 mg (ii) meglumine diatrizoate 520 mg (total iodine conc.60 percentage), injection diazepam 5 mg/ml, 64700, each ml contains:- etoposide ip 20 mg, fentanyl citrate injection 50 mcg/ml, 187000, each 2 ml contains gentamicin sulphate ip eq. to gentamicin 80 mg, an cl
ass="text-red-selected">hep
atitisan> b v
accine (r-dn
a)(1ml
ampl ), 120300, mfgd. by recombin
ant dn
a technology strength of v
accine 20 mcg/ml,
injection mephentermine 15 mg/ml, 81500, e
ach 100 ml cont
ains:dextrose
anhydrous ip 5gm; sodium chloride ip 0.091gm; sodium
acet
ate ip 0.280gm; pot
asium chloride ip 0.150gm; dib
asic pot
asium phosph
ate usp 0.130gm; &
amp; sterile w
ater for
injection ip q.s.,
injection oxytocin 5 i.u./ml, 1666900, e
ach ml cont
ain:-phenytoin sodium ip 50mg,, polygelin iv prep
ar
ation (pl
asm
a exp
anding iv fluid) (3.5percent
age infusion solution for iv,sterile
and pyrogen free), 309300, e
ach ml cont
ains :
anti r
abies immunoglobulin 150 iu